Pharmaceutical Executive

Pharmaceutical Executive Podcast

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.

Subscribe Listen in podnod RSS feed Show website

413 episodes
Updated Yesterday

Episodes413

Newest first

May 11, 2022 · 17 min
Behind the Creative...Inspiring Award Winning Creative with Troy Clark and Anne Brown
Biolumina's Troy Clark, SVP, Creative Director, and Anne Brown, SVP, Creative Director, Copy discuss their APEX-award winning website "Be in the Know" for AstraZeneca's metastatic non-small cell lung cancer (NSCLC) disease state education efforts.
Apr 28, 2022 · 20 min
The Pulse Of Oncology
In episode 107, Camille Hertzka, VP, head of oncology US medical at AstraZeneca, talks about her experience as a leader in oncology over the years and to expect from the space moving into the future.
Apr 14, 2022 · 11 min
Changing Cancer Care with CAR-T
In episode 106, Christi Shaw, CEO of Kite, a Gilead Company, talks about how CAR T-cell therapies are impacting cancer care and the lessons she’s learned along her career path.
Mar 31, 2022 · 17 min
A Look at Latin America
In episode 105, Rolf Hoenger,  area head of Latin America at Roche  Pharma, talks about the current pharma landscape in Latin America and his experiences as a leader in this area.
Mar 17, 2022 · 15 min
The Art of Science
In episode 104, Susanne Schaffert, president of Novartis Oncology, discusses her career journey, which has combined both a passion for the arts and science, and how she believes the two can work together in pharma.
Mar 3, 2022 · 10 min
Respiratory Issues
Robert Clarke, CEO and co-founder of Kinaset Therapeutics, talks about developing inhaled therapies to fight asthma and COPD, which is especially relevant as COVID-19 poses significant problems for sufferers.
Feb 17, 2022 · 19 min
Serving an Aging Population
In episode 102, Mike Devoy, chief medical officer of Bayer, also executive vice president of medical affairs and pharmacovigilance for Bayer’s Pharmaceuticals Division, discusses how innovation, including the digitalization of healthcare delivery, and breakthrough technologies can help people make the most out of the longer lives they’re living today.
Feb 3, 2022 · 12 min
Digital Awareness
Bruno Larvol, CEO and founder of Larvol, discusses how he is invested in the digital world, both personally and professionally, and the impact it can have.
Jan 20, 2022 · 25 min
Industry Outlook 2022
Our milestone 100th episode includes Lisa Henderson, group editorial director; Julian Upton, European and online editor; Fran Pollaro, senior editor; and Andy Studna, associate editor, discussing industry trends in areas such as Chinese biotech, corporate branding, psychedelic medicines, and market access barriers that they've written up for our January issue. Read them here: https://www.pharmexec.com/view/our-view-on-2022-pharm-exec-s-annual-industry-outlook
Jan 6, 2022 · 14 min
Episode 99: Caring About Specialty
Bill Sibold, executive vice president and head of Sanofi Genzyme, talks about his work in specialty care over the past 10 years and what makes it unique.
Dec 23, 2021 · 16 min
Episode 98: Family Run Pharma
Giacomo Chiesi, Head of Global Rare Diseases at the Chiesi Group, discusses what it has been like growing up around pharma, and how he’s turned a family passion into his own dedicated career path.
Dec 9, 2021 · 17 min
Episode 97: Diving Into Pharm Exec’s 2022 Pipeline Report
Mike Ward, Global Head of Thought Leadership in the Decision Resources Group at Clarivate, discusses PharmExec’s 2022 pipeline report, which appears in our December issue. Mike goes behind the numbers and provides some interesting insights from the report provided by Clarivate.
Nov 25, 2021 · 19 min
Episode 96: Forging New Paths In Oncology
Tim Whitten, CEO and president of Taiho Oncology, discusses how innovative thinking—from developing new therapies to creating a podcast for employees during COVID—has played an important role in his professional journey.
Nov 11, 2021 · 10 min
Episode 95: CEOs Share Their Industry Outlook
Jeff Stoll, US Life Sciences Strategy Leader at KPM, talks about some of the highlights from KPMG’s recent Global Pharma CEO Outlook report.
Oct 28, 2021 · 19 min
Episode 94: Women Leading The Way
Amie Krause, Senior Vice President and Chief People Officer, and Kristin Yarema, Chief Commercial Officer, of Atara Biotherapeutics, talk about gender diversity in the c-suite and how that can benefit a company both internally and externally.
Oct 14, 2021 · 13 min
Episode 93: Cultural Cues in Oncology
Michael Petroutsas, Senior Vice President and Head of GSK’s US Oncology Business Unit, talks about how his background has taught him the importance of connecting with patients on their level and how he brings that mentality to GSK.
Sep 30, 2021 · 21 min
Episode 92: Digesting The GI Market
Tom McCourt, CEO of Ironwood Pharmaceuticals, talks about his 30-plus years in the gastrointestinal space, including his experiences bringing top GI medicines Prilosec, Nexium, Entocort, Zelnorm, and Linzess to market.
Sep 16, 2021 · 18 min
Episode 91: A New Way to Partner With Academia
Dr. Michael Henderson, chief business officer of BridgeBio Pharma, and one of Pharm Exec’s 2021 Emerging Pharma Leaders, discusses how his company goes beyond the traditional “hand off” approach between academia and industry, and looks to partner with institutions early on to fill important voids in drug development.
Sep 2, 2021 · 11 min
Episode 90: Innovating Ways to Fight Cancer
Dr. Edith Perez, Chief Medical Officer of Bolt Biotherapeutics, discusses how she approaches drug development in oncology, and what she contributes outside of work to help raise awareness for cancer.
Aug 19, 2021 · 16 min
Episode 89: Cellicon Valley Outlook
Audrey Greenberg, co-founder and executive managing director of the Center for Breakthrough Medicines and Discovery Labs, discusses how cell and gene therapy has turned Philadelphia into Cellicon Valley, and how her organization is playing a role in that growth even beyond the city’s boarders.